These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7541228)

  • 1. In search of the 'bio-active conformation'--is it induced by the target cell membrane?
    Schwyzer R
    J Mol Recognit; 1995; 8(1-2):3-8. PubMed ID: 7541228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 100 years lock-and-key concept: are peptide keys shaped and guided to their receptors by the target cell membrane?
    Schwyzer R
    Biopolymers; 1995; 37(1):5-16. PubMed ID: 7880967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycopeptide-membrane interactions: glycosyl enkephalin analogues adopt turn conformations by NMR and CD in amphipathic media.
    Palian MM; Boguslavsky VI; O'Brien DF; Polt R
    J Am Chem Soc; 2003 May; 125(19):5823-31. PubMed ID: 12733923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational and topographical considerations in the design of biologically active peptides.
    Hruby VJ
    Biopolymers; 1993 Jul; 33(7):1073-82. PubMed ID: 8102072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR studies of the structure and dynamics of peptide E, an endogenous opioid peptide that binds with high affinity to multiple opioid receptor subtypes.
    Yan C; Digate RJ; Guiles RD
    Biopolymers; 1999 Jan; 49(1):55-70. PubMed ID: 10070262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective opioid dipeptides.
    Temussi PA; Salvadori S; Amodeo P; Bianchi C; Guerrini R; Tomatis R; Lazarus LH; Picone D; Tancredi T
    Biochem Biophys Res Commun; 1994 Feb; 198(3):933-9. PubMed ID: 8117299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and regulation of opioid receptors.
    Chaturvedi K; Christoffers KH; Singh K; Howells RD
    Biopolymers; 2000; 55(4):334-46. PubMed ID: 11169924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the bioactive form and molecular determinants of recognition of cyclic enkephalin peptides at the delta-opioid receptor.
    Chew C; Villar HO; Loew GH
    Biopolymers; 1993 Apr; 33(4):647-57. PubMed ID: 8385507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Opioid peptides].
    Neuzil E; Cassaigne A
    Expos Annu Biochim Med; 1982; 35():161-214. PubMed ID: 6277687
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutational analysis of the structure and function of opioid receptors.
    Law PY; Wong YH; Loh HH
    Biopolymers; 1999; 51(6):440-55. PubMed ID: 10797232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A turning point in the knowledge of the structure-function-activity relations of elastin].
    Alix AJ
    J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformation-activity relationships of opioid peptides with selective activities at opioid receptors.
    Hruby VJ; Agnes RS
    Biopolymers; 1999; 51(6):391-410. PubMed ID: 10797229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.
    Lung FD; Collins N; Stropova D; Davis P; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Mar; 39(5):1136-41. PubMed ID: 8676350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling suggests conformational scaffolds specifically targeting five subtypes of somatostatin receptors.
    Nikiforovich GV; Marshall GR; Achilefu S
    Chem Biol Drug Des; 2007 Mar; 69(3):163-9. PubMed ID: 17441902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological and functional biochemical properties of D-Ala2-D-Nle5-enkephalin-Arg-Phe.
    Tóth F; Horváth G; Szikszay M; Farkas J; Tóth G; Borsodi A; Benyhe S
    Regul Pept; 2004 Oct; 122(2):139-46. PubMed ID: 15380931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a novel class of neuromedin B receptor antagonists, substituted somatostatin analogues.
    Orbuch M; Taylor JE; Coy DH; Mrozinski JE; Mantey SA; Battey JF; Moreau JP; Jensen RT
    Mol Pharmacol; 1993 Oct; 44(4):841-50. PubMed ID: 7901752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2.
    Vig BS; Zheng MQ; Murray TF; Aldrich JV
    J Med Chem; 2003 Sep; 46(19):4002-8. PubMed ID: 12954053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-membrane interactions and a new principle in quantitative structure-activity relationships.
    Schwyzer R
    Biopolymers; 1991 May; 31(6):785-92. PubMed ID: 1657234
    [No Abstract]   [Full Text] [Related]  

  • 19. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection.
    Bader R; Bettio A; Beck-Sickinger AG; Zerbe O
    J Mol Biol; 2001 Jan; 305(2):307-29. PubMed ID: 11124908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant opioid receptors. Structure-function relationship.
    Filipovska J; Gomes I; Xu W; Chen C; Liu-Chen LY; Devi LA
    Methods Mol Med; 2003; 84():185-203. PubMed ID: 12703324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.